HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alberto Zanchetti Selected Research

Felodipine (Agon)

6/2011Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.
10/2010Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study.
12/2005The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alberto Zanchetti Research Topics

Disease

65Hypertension (High Blood Pressure)
01/2019 - 01/2000
19Stroke (Strokes)
11/2017 - 11/2002
16Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 11/2002
14Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2016 - 09/2002
13Atherosclerosis
12/2014 - 11/2002
9Heart Failure
11/2017 - 05/2002
8Coronary Disease (Coronary Heart Disease)
07/2015 - 02/2002
7Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2019 - 01/2004
7Carotid Artery Diseases
07/2012 - 11/2002
6Myocardial Infarction
11/2017 - 11/2002
6Diabetes Mellitus
01/2017 - 11/2002
6Type 2 Diabetes Mellitus (MODY)
09/2008 - 03/2006
5Essential Hypertension
11/2010 - 09/2002
5Hypertrophy
04/2009 - 09/2002
4Isolated Systolic Hypertension
01/2018 - 04/2004
4Obesity
02/2016 - 02/2002
4Cognitive Dysfunction
09/2014 - 05/2003
4Hemorrhage
04/2012 - 11/2002
3Proteinuria
01/2016 - 11/2006
3Fever (Fevers)
06/2011 - 12/2005
3Overweight
12/2008 - 04/2005
2Inflammation (Inflammations)
12/2016 - 02/2014
2Chronic Renal Insufficiency
02/2014 - 09/2010
2Neoplasms (Cancer)
04/2012 - 12/2005
2Cardiomegaly (Heart Hypertrophy)
02/2010 - 11/2002
2Abdominal Obesity
04/2009 - 08/2005
2Fibrosis (Cirrhosis)
03/2009 - 08/2004
2Atrial Fibrillation
03/2008 - 01/2008
2Dizziness (Lightheadedness)
02/2008 - 01/2006
2Cough
01/2006 - 11/2002
2Edema (Dropsy)
02/2003 - 11/2002
1Hyperglycemia
07/2019
1Prediabetic State (Prediabetes)
01/2019
1Left Ventricular Dysfunction
11/2017
1White Coat Hypertension
12/2014
1Vascular Diseases (Vascular Disease)
05/2009
1Arthralgia (Joint Pain)
02/2008
1Weight Loss (Weight Reduction)
02/2008
1Nausea
02/2008

Drug/Important Bio-Agent (IBA)

60Antihypertensive Agents (Antihypertensives)IBA
01/2019 - 02/2001
13lacidipineIBA
12/2014 - 11/2002
12Atenolol (Tenormin)FDA LinkGeneric
07/2012 - 09/2002
10Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2019 - 05/2002
9CalciumIBA
03/2016 - 11/2002
9CreatinineIBA
01/2008 - 02/2001
8Valsartan (Vals)FDA Link
03/2012 - 06/2004
8candesartanIBA
03/2009 - 11/2002
7CholesterolIBA
07/2019 - 02/2002
7Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 02/2001
7Pharmaceutical PreparationsIBA
11/2017 - 04/2003
7Angiotensin Receptor AntagonistsIBA
07/2015 - 11/2002
7Hydrochlorothiazide (Esidrix)FDA LinkGeneric
06/2011 - 11/2002
7Amlodipine (Norvasc)FDA LinkGeneric
01/2008 - 11/2002
6DiureticsIBA
07/2015 - 04/2003
6Glucose (Dextrose)FDA LinkGeneric
01/2007 - 03/2003
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2014 - 02/2003
5Blood Glucose (Blood Sugar)IBA
02/2014 - 02/2002
5Angiotensin IIIBA
11/2010 - 09/2002
4HDL CholesterolIBA
02/2014 - 01/2004
4AlbuminsIBA
01/2006 - 06/2004
3Triglycerides (Triacylglycerol)IBA
07/2019 - 01/2004
3LDL CholesterolIBA
09/2014 - 01/2004
3Felodipine (Agon)FDA LinkGeneric
06/2011 - 12/2005
3Retinaldehyde (Retinal)IBA
06/2009 - 01/2004
3Angiotensin Receptors (Angiotensin II Receptor)IBA
03/2008 - 12/2002
3Losartan (Cozaar)FDA LinkGeneric
01/2006 - 09/2002
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2006 - 05/2002
2oxidized low density lipoproteinIBA
09/2014 - 09/2014
2Uric Acid (Urate)IBA
02/2014 - 06/2007
2SaltsIBA
02/2014 - 08/2013
2Olmesartan Medoxomil (Votum)FDA Link
07/2012 - 11/2010
2EnalaprilFDA LinkGeneric
03/2009 - 11/2002
2LipidsIBA
02/2008 - 12/2004
2Mydriatics (Cycloplegics)IBA
11/2004 - 01/2004
2Angiotensin II Type 1 Receptor BlockersIBA
09/2004 - 12/2002
2candesartan cilexetil (Amias)FDA Link
11/2002 - 01/2002
1Metformin (Glucophage)FDA LinkGeneric
01/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
1Dihydrotachysterol (AT 10)IBA
07/2017
1Peptides (Polypeptides)IBA
01/2017
1QuercetinIBA
12/2016
1AntioxidantsIBA
12/2016
13-hydroxyflavoneIBA
12/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
02/2016
1ElectrolytesIBA
06/2014
1Chlorthalidone (Chlortalidone)FDA LinkGeneric
04/2012
1IndapamideFDA LinkGeneric
04/2012
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2012
1Ramipril (Altace)FDA LinkGeneric
11/2010
1UromodulinIBA
10/2010
1SodiumIBA
10/2010
1A 17 (A-17)IBA
12/2008
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
09/2008
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2008
1CannabinoidsIBA
02/2008
1RimonabantIBA
02/2008

Therapy/Procedure

26Therapeutics
01/2019 - 01/2000
2Secondary Prevention
09/2014 - 05/2009
1Precision Medicine
01/2019
1Denervation
12/2016